Major Breakthrough in Cancer Treatment
In a recent medical trial in the USA, 12 patients were completely cured of rectal cancer without requiring any surgery or chemotherapy.
The trial used a monoclonal antibody - dostarlimab - every three weeks for six months for the treatment of a particular kind of stage two or three rectal cancer.
About Monoclonal Antibodies
- A Monoclonal Antibody is a type of protein (immunoglobulin) that is made in the laboratory from a single B-cell clone and can bind to certain targets in the body, such as antigens on the surface of cancer cells.
- There are many kinds of monoclonal antibodies, and each monoclonal ....
Do You Want to Read More?
Subscribe Now
To get access to detailed content
Already a Member? Login here
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material since 2018 of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Science & Technology
- 1 Japan-India Collaboration on Space Debris Removal
- 2 CE20 Cryogenic Engine: ISRO Achieves Major Milestone
- 3 India’s Zorawar Light Tank Hits Major Milestone
- 4 Cellular-Level Map of Growing Foetal Brains
- 5 New Breakthrough in Haemophilia Treatment
- 6 Hybrid Aerogel for Gold Extraction from E-Waste
- 7 Kisan Kavach Suit
- 8 SpaceX Launches ISRO's GSAT-20 Satellite
- 9 First Analog Space Mission
- 10 NISAR Satellite to Monitor Earth’s Surface Changes
